Skip to Content for 2007 Annual Report Menu for 2007 Annual Report About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image

2007 Annual Report

Editorial Financials

11-Year Financial Summary (Unaudited)
(In millions, except per share, stock price and employee data)

2007-2004 2003-2000 1999-1997

2007-2004

Years Ended December 31, 2007

2006

2005

2004

TOTAL OPERATING REVENUE $11,724 $9,284 $6,633 $4,621
  Product sales 9,443 7,640 5,488 3,749
  Royalties(1) 1,984 1,354 935 641
  Contract revenue 297 290 210 231
TOTAL COSTS AND EXPENSES $7,495 $6,132 $4,712 $3,485
  Cost of sales  1,571  1,181  1,011  673
  Research and development  2,446  1,773  1,262  948
  Marketing, general and administrative  2,256  2,014  1,435  1,088
  Collaboration profit sharing  1,080  1,005  823  594
  Write-off of in-process research and development related to acquisition(1)  77  -  -  -
  Gain on acquisition(1)  (121)  -  -  -
  Recurring charges related to redemption and acquisition(2)  132  105  123  145
  Special items 54(15) 54(15)  58(15)  37(15)
Other income, net $   197 $   251 $   92 $   84
INCOME (LOSS) DATA        
  Income (loss) before taxes and cumulative effect of accounting change  $4,426  $3,403  $2,013  $1,220
  Income tax (benefit) provision 1,657 1,290  734  435
  Income (loss) before cumulative effect of accounting change
2,769

2,113

1,279

785
  Cumulative effect of accounting change, net of tax  -  -  -  -
  Net income (loss)
2,769

2,113

1,279

785
EARNINGS (LOSS) PER SHARE:        
  Basic: Earnings before cumulative effect of accounting change $   2.63 $   2.01 $   1.21 $   0.74
    Cumulative effect of accounting change, net of tax  -  -  -  -
   
Net earnings per share

$   2.63

$   2.01

$   1.21

$   0.74
  Diluted: Earnings before cumulative effect of accounting change
$   2.59

$   1.97

$   1.18

$   0.73
    Cumulative effect of accounting change, net of tax  -  -  -  -
   
Net earnings per share

$   2.59

$   1.97

$   1.18

$   0.73
SELECTED BALANCE SHEET DATA        
  Cash, cash equivalents, short-term investments, and long-term marketable debt and equity securities  $6,065  $4,325  $3,814  $2,780
  Accounts receivable 1,766 1,666 1,050  941
  Inventories  1,493  1,178  703  590
  Property, plant and equipment, net 4,986 4,173 3,349 2,091
  Goodwill   1,577   1,315   1,315   1,315
  Other intangible assets  1,168  476  574   668
  Other long-term assets 366(14) 1,342(14) 1,074(14) 807(14)
  Total assets   18,940   14,842   12,147   9,403
  Commercial paper   599(19)   -   -   -
  Total current liabilities   3,918   2,010   1,660   1,238
  Long-term debt 2,402(17), (18) 2,204(17), (18) 2,083(17), (18)   412
  Total liabilities   7,035   5,364   4,677   2,621
  Total stockholders' equity   11,905   9,478   7,470   6,782
OTHER DATA        
  Depreciation and amortization expense $  492 $  407 $  370 $  353
  Capital expenditures  977(18)  1,214(18)  1,400(18)  650
SHARE INFORMATION        
  Shares used to compute basic earnings per share  1,053  1,053  1,055  1,055
  Shares used to compute diluted earnings per share  1,069  1,073  1,081  1,079
  Shares outstanding at year-end  1,052  1,053  1,054  1,047
PER SHARE DATA        
  Market price:      High $ 89.73 $ 95.16 $ 100.20 $   68.25
         Low $ 65.35 $ 75.58 $   43.90 $   41.00
  Book value $   11.32 $   9.00 $     7.09 $     6.48
NUMBER OF EMPLOYEES AT YEAR-END  11,174   10,533   9,563  7,646

(Table Continued below)

2003-2000

Years Ended December 31, 2003

2002

2001

2000

TOTAL OPERATING REVENUE $3,300 $2,584 $2,044 $1,514
  Product sales 2,621 2,164 1,743 1,278
  Royalties(1) 501 366 264 207
  Contract revenue 178 54 37 29(9)
TOTAL COSTS AND EXPENSES $2,495 $2,662 $1,896 $1,726
  Cost of sales  480  442  354  365(6)
  Research and development  722  623  526  490
  Marketing, general and administrative  795  546  447  367
  Collaboration profit sharing  457  351  247  129
  Write-off of in-process research and development related to acquisition(1)  -  -  -  -
  Gain on acquisition(1)  -  -  - -
  Recurring charges related to redemption and acquisition(2)  154  156(12)  322  375
  Special items  (113)(15) 544(13)   -   -
Other income, net  $  92  $  108 $135(10) $  216
INCOME (LOSS) DATA        
  Income (loss) before taxes and cumulative effect of accounting change  $ 897  $   30  $  283  $     4
  Income tax (benefit) provision  287  (34)  127  20
  Income (loss) before cumulative effect of accounting change
610

64

156

(16)
  Cumulative effect of accounting change, net of tax  (47)(16)  -  (6)(10)  (58)(9)
  Net income (loss)
563

64(12)

150

(74)
EARNINGS (LOSS) PER SHARE:        
  Basic: Earnings before cumulative effect of accounting change $   0.59  $   0.06  $    0.15  $ (0.02)
    Cumulative effect of accounting change, net of tax  (0.05)  -  (0.01)  (0.05)
   
Net earnings per share

$   0.54

$   0.06

$    0.14

$ (0.07)
  Diluted: Earnings before cumulative effect of accounting change
$   0.58

$   0.06

$    0.15

$ (0.02)
    Cumulative effect of accounting change, net of tax  (0.05)  -  (0.01)  (0.05)
   
Net earnings per share

$   0.53

$   0.06

$    0.14

$ (0.07)
SELECTED BALANCE SHEET DATA        
  Cash, cash equivalents, short-term investments, and long-term marketable debt and equity securities  $2,935  $1,602  $2,865  $2,459
  Accounts receivable  588  432  321  278
  Inventories  470  394  357  266
  Property, plant and equipment, net 1,618(16)  1,069  866  753
  Goodwill   1,315  1,315  1,303  1,456
  Other intangible assets   811  928  1,113  1,280
  Other long-term assets 822(14)  801(14)  136  175
  Total assets   8,759  6,776  7,162  6,739
  Commercial paper   -  -  -  -
  Total current liabilities   893  661  677(11)  475
  Long-term debt   412(16)  -  -  150
  Total liabilities   2,239  1,437  1,242  1,065
  Total stockholders' equity   6,520  5,339  5,920   5,674
OTHER DATA        
  Depreciation and amortization expense $  295 $275(12)  $  428  $   463
  Capital expenditures  322  323  213  113
SHARE INFORMATION        
  Shares used to compute basic earnings per share  1,035  1,038  1,054  1,044
  Shares used to compute diluted earnings per share  1,058  1,049  1,071  1,044
  Shares outstanding at year-end  1,049  1,026  1,057  1,051
PER SHARE DATA        
  Market price:      High $   47.68  $  27.58  $  42.00  $  61.25
         Low $   15.77  $  12.55  $  19.00  $  21.13
  Book value $     6.21  $    5.21  $    5.60  $    5.40
NUMBER OF EMPLOYEES AT YEAR-END    6,226  5,252 4,950  4,459

(Table Continued below)

1999-1997

Years Ended December 31,   1999

1998

1997

TOTAL OPERATING REVENUE   $1,292 $1,053 $936
  Product sales   1,039 718 585
  Royalties(1)   189 230 241
  Contract revenue   64 105 110
TOTAL COSTS AND EXPENSES   $2,730 $  874 $  840
  Cost of sales    286(6) 139 103
  Research and development    367 396 471
  Marketing, general and administrative    367 299 266
  Collaboration profit sharing    74 40 -
  Write-off of in-process research and development related to acquisition(1)    - - -
  Gain on acquisition(1)    - - -
  Recurring charges related to redemption and acquisition(2)     198 - -
  Special items    1,438(7) - -
Other income, net   $   78 $   74 $   74
INCOME (LOSS) DATA        
  Income (loss) before taxes and cumulative effect of accounting change    $(1,360) $  253 $  170
  Income tax (benefit) provision    (203) 71 41
  Income (loss) before cumulative effect of accounting change  
(1,157)

182

129
  Cumulative effect of accounting change, net of tax    - - -
  Net income (loss)  
(1,157)

182

129
EARNINGS (LOSS) PER SHARE:        
  Basic: Earnings before cumulative effect of accounting change    $ (1.13) $   0.18 $   0.13
    Cumulative effect of accounting change, net of tax    - - -
   
Net earnings per share
 
$ (1.13)

$   0.18

$   0.13
  Diluted: Earnings before cumulative effect of accounting change  
$ (1.13)

$   0.18

$   0.13
    Cumulative effect of accounting change, net of tax    - - -
   
Net earnings per share
 
$ (1.13)

$   0.18

$   0.13
SELECTED BALANCE SHEET DATA        
  Cash, cash equivalents, short-term investments, and long-term marketable debt and equity securities    $1,957 $1,605 $1,287
  Accounts receivable    233 158 184
  Inventories    275 149 116
  Property, plant and equipment, net    730 700 683
  Goodwill    1,609 - -
  Other intangible assets    1,453 65 55
  Other long-term assets    206 135 128
  Total assets    6,561 2,868 2,507
  Commercial paper   - - -
  Total current liabilities    503 303 289
  Long-term debt    150 150 150
  Total liabilities     1,291 524 476
  Total stockholders' equity   5,270(8) 2,344 2,031
OTHER DATA        
  Depreciation and amortization expense    $   281 $   78 $   66
  Capital expenditures    95 88 155
SHARE INFORMATION        
  Shares used to compute basic earnings per share    1,026 1,007 984
  Shares used to compute diluted earnings per share    1,026 1,039 1,011
  Shares outstanding at year-end    1,032 1,017 994
PER SHARE DATA        
  Market price:      High    $  11.25 $   9.97 $   7.58
        $35.75*    
         Low    $  9.32 $   7.41 $   6.66
        $12.13*    
  Book value    $    5.10 $   2.30 $   2.04
NUMBER OF EMPLOYEES AT YEAR-END    3,883 3,389 3,242

 

Reconciliation of GAAP to Non-GAAP Net Income (Unaudited)
(In millions, except per share amounts)

Years Ended December 31, 2007

2006

2005

2004

GAAP net income (loss) $2,769 $2,113 $1,279 $785
Royalty revenue(1) (6) - - -
Employee stock-based compensation expense(3) under FAS 123R included in the following operating expenses:        
     Cost of sales 71 - - -
     Research and development 153 140 - -
     Marketing, general and administrative 179 169 - -
Write-off of in-process research and development related to acquisition(1) 77 - - -
Gain on acquisition(1) (121) - - -
Recurring charges related to redemption and acquisition(2) 132 105 123 145
Special items  54(15)  54(15)  58(15) 37(15)
Other Non-GAAP reconciling items  -  - - -
Income tax effect(4)  (166)  (191)  (73) (73)
Income before cumulative effect of accounting change
 3,142

 2,390

1,387

894
Cumulative effect of accounting change, net of tax  -  - - -
Non-GAAP net income
$   3,142

$   2,390

$   1,387

$   894
Non-GAAP earnings per share:



     Diluted $   2.94 $   2.23 $   1.28 $   0.83
Non-GAAP weighted average shares used to compute earnings per share:



     Diluted 1,068(20) 1,074(20) 1,081 1,079

(Table Continued below)

Years Ended December 31, 2003

2002

2001

2000

1999

GAAP net income (loss) $563 $64 $150 $(74) $(1,157)
Royalty revenue(1) - - - - -
Employee stock-based compensation expense(3) under FAS 123R included in the following operating expenses:          
     Cost of sales - - - - -
     Research and development - - - - -
     Marketing, general and administrative - - - - -
Write-off of in-process research and development related to acquisition(1) - - - - -
Gain on acquisition(1) - - - - -
Recurring charges related to redemption and acquisition(2) 154 156(12) 322 375 198
Special items  (113)(15)  544(13)  - -  1,438(7)
Other Non-GAAP reconciling items  -  - (10)(10) 93(6) 93(6)
Income tax effect(4)  (16)  (280)  (64) (127) (325)
Income before cumulative effect of accounting change
 588

 484

398

267

 247
Cumulative effect of accounting change, net of tax  47(16)  - 6(10) 58(9)  -
Non-GAAP net income
$   635

$  484

$  404

$  325

$  247
Non-GAAP earnings per share:




     Diluted $   0.60 $  0.46 $   0.38 $   0.30 $   0.23
Non-GAAP weighted average shares used to compute earnings per shar